Viewbix Stock Price, News & Analysis

Viewbix (Nasdaq: VBIX) received majority stockholder written consent to proceed with its previously announced acquisition of Quantum X Labs, entered under a definitive share purchase agreement dated Dec 15, 2025. The deal contemplates Viewbix acquiring 85%–100% of Quantum on a fully diluted basis and transfers Quantum's IP portfolio, including quantum algorithms, navigation/GPS alternatives, atomic clocks, and quantum error correction technology.

At closing Viewbix will issue common stock and pre-funded warrants equal to approximately 40% of its capital stock as of the Agreement Date (including 800,000 shares in a related private placement) with up to 12,702,847 additional shares or pre-funded warrants payable upon milestone achievement. Closing remains subject to due diligence and regulatory approvals; the company expects the transaction to close in the coming weeks and will file a Schedule 14C information statement.

Viewbix (NASDAQ: VBIX) signed a definitive agreement to acquire between 85% and 100% of Quantum X Labs, an Israeli multi-disciplinary quantum hub, with closing expected within 90 days of the December 15, 2025 execution date.

Quantum X Labs houses five portfolio companies across navigation, error correction, algorithms for biomedicine, atomic clocks, and quantum security, and claims a quantum error correction approach that can cut computational overhead by up to 50%. The deal includes an expanding patent portfolio and existing sub-licensing collaboration with Ramot, and remains subject to regulatory approvals, stockholder consent, final due diligence, and customary closing conditions.

Viewbix (NASDAQ: VBIX) announced that Quantum X Labs filed a provisional patent on Dec 22, 2025 titled "Generating Quantum Markov Chain Monte Carlo Sampling Points for Continuous Distribution Functions". The technology applies quantum-enhanced MCMC to sample complex continuous probability distributions and is being developed with portfolio company Cliniquantum to map biological data, identify latent patient clusters, and model probabilistic treatment responses with higher resolution.

Viewbix signed a definitive agreement on Dec 15, 2025 to acquire 85%–100% of Quantum X Labs; the acquisition is expected to close within 90 days of execution, subject to due diligence, regulatory approvals, and stockholder approval under Nasdaq rules.

Viewbix (Nasdaq: VBIX) entered a definitive share purchase agreement to acquire between 85%–100% of Quantum X Labs, subject to closing conditions and approvals on or before 90 calendar days from Dec 16, 2025.

At closing, Viewbix will issue common stock and pre-funded warrants equal to about 40% of issued capital (inclusive of a concurrent $3 million PIPE), with up to an additional 25% of capital payable on post-close milestones. The deal includes Quantum’s four portfolio companies and a patent for AI-quantum error correction claiming up to a 50% reduction in surface-code decoding overhead.

Viewbix (Nasdaq: VBIX) signed an updated non-binding term sheet to acquire 100% of Quantum X Labs via an equity-for-stock transaction that now reduces Viewbix’s initial equity issuance to 40.0% of post-closing capital, inclusive of a $3.0 million PIPE announced Nov 5, 2025. The deal includes performance-based earn-outs that can increase total issuance up to 65.0% of outstanding stock upon achievement of three milestone tranches (6%, 8%, 11%) tied to prototype phases, partnerships, technical validation or patent filings within 18–36 months.

Closing remains subject to due diligence, definitive agreements, Nasdaq and shareholder approvals, and customary conditions; the PIPE is expected to close in December 2025.

Viewbix (Nasdaq: VBIX) announced on November 12, 2025 that it closed the strategic sale of its digital content subsidiary Cortex Media Group to Pro Sportority (Israel) Ltd., a subsidiary of Minute Media, owner of Sports Illustrated publishing rights.

The divestiture aligns with Viewbix’s stated shift away from legacy digital advertising toward high‑growth areas. The company also disclosed a non‑binding term sheet to acquire Quantum X Labs Ltd as it seeks to enter quantum computing and advanced computational technologies. Further transaction details will appear in a Form 8‑K to be filed with the SEC.

Viewbix (Nasdaq: VBIX) announced a private placement to raise approximately $3.0 million through the sale of an aggregate of 800,000 units and pre-funded units, priced at a premium to the November 4, 2025 closing share price.

Each common unit sells at $3.75 and includes one common share plus one common warrant exercisable for one share at $5.625 (5-year term). Pre-funded units substitute a pre-funded warrant for the share and include the same common warrant. Closing is expected in December 2025, subject to customary conditions, Nasdaq shareholder approval, and execution of definitive agreements for Viewbix’s proposed acquisition of Quantum X Labs Ltd. Net proceeds are intended for general corporate purposes, working capital and debt repayment.

Viewbix (Nasdaq: VBIX) signed a non-binding term sheet to acquire 100% of Quantum X Labs in a security-exchange transaction, with closing expected in December 2025 subject to due diligence, definitive agreements, regulatory approvals, and shareholder vote.

Under the proposal, Quantum X Labs shareholders would receive common stock and pre-funded warrants representing 65% of Viewbix's post-closing share capital, inclusive of a concurrently announced $3.0 million PIPE. Quantum X Labs is described as an Israeli quantum computing and AI company with patent-protected subsidiaries focused on quantum algorithmics and physics.

Viewbix (Nasdaq: VBIX), a global ad-tech technology developer, has announced two significant developments. The company successfully completed an uplisting to the Nasdaq Capital Market on June 5, 2025, followed by a private placement that raised approximately $4.5 million from strategic institutional investors.

Following these developments, Viewbix plans to explore new business opportunities, investments, and activities across various sectors, marking a potential strategic shift for the company.